PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY. Вопр. онкол. [Internet]. 2020 Feb. 1 [cited 2026 Oct. 14];66(2):135-42. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1065